Clinical Trial Update: Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated the efficacy and safety of sodium alginate oral suspension for non-erosive gastroesophageal reflux disease; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Gastroesophageal Reflux Disease

Drugs mentioned

• Sodium alginate oral suspension (sodium alginate)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Gastroesophageal Reflux Disease, Heartburn | Phase 3 | Status: COMPLETED